Curis

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Curis and other ETFs, options, and stocks.

About CRIS

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327.

CEO

James E. Dentzer

CEOJames E. Dentzer

Employees

Employees34

Headquarters

Lexington, Massachusetts

HeadquartersLexington, Massachusetts

Founded

2000

Founded2000

Employees

Employees34

CRIS Key Statistics

Market cap

21.45M

Market cap21.45M

Price-Earnings ratio

-0.33

Price-Earnings ratio-0.33

Dividend yield

—

Dividend yield—

Average volume

114.48K

Average volume114.48K

High today

$2.22

High today$2.22

Low today

$1.90

Low today$1.90

Open price

$2.05

Open price$2.05

Volume

67.99K

Volume67.99K

52 Week high

$12.66

52 Week high$12.66

52 Week low

$1.02

52 Week low$1.02

People also own

Based on the portfolios of people who own CRIS. This list is generated using Robinhood data, and it’s not a recommendation.